Dr. Jan Egebjerg
PhD, is Head of Neurodegeneration department at Janssen since 2018.
Previously he was Divisional Director for Neurodegeneration at H. Lundbeck A/S and ass. professor at Dept for Molecular Biology, University of Aarhus.
His main focus is to develop novel treatments with neurodegenerative disorders by integrating and transition basic research finding into drug discovery projects and establish translational markers between preclinical models and clinical relevant measures. His main research interest has been molecular neurobiology and pharmacology with focus on glutamatergic signaling.
He is also member of the Danish strategic research council, program commission on “Individuals, Disease and Society” and serves at several scientific advisory boards supporting CNS research.